Exophthalmos
Information
- Disease name
- Exophthalmos
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05276063 | Active, not recruiting | Phase 2/Phase 3 | A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) | July 1, 2022 | September 2026 |
| NCT04025034 | Completed | N/A | Deep Lateral Wall Partial Rim-Sparing Orbital Decompression for Treatment of Thyroid-Related Orbitopathy | January 2015 | January 1, 2019 |
| NCT06112340 | Recruiting | Phase 2/Phase 3 | A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) | October 11, 2023 | June 2026 |
| NCT01204359 | Unknown status | Phase 3 | The Prospective Study of Standard Treatment of Graves Disease Iodine 131 and Prevention of Adverse Reactions | July 2007 | December 2016 |
| NCT04704414 | Unknown status | N/A | Exophthalmometry With 3D Face Scanners | August 14, 2019 | December 31, 2022 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D005094